Saturday, October 03, 2026

 

Monitoring online health misinformation can help create useful patient education content



Getting ahead of health misinformation trends can minimize their negative impacts



American Academy of Pediatrics






SAN DIEGO — Pediatric clinicians can learn useful information by tracking the health misinformation that their patients encounter, according to research presented during the American Academy of Pediatrics 2026 National Conference & Exhibition Oct. 2-6, 2026, at the San Diego Convention Center.

Researchers created a survey to collect data from medical professionals on what misinformation they heard from patients, the category it fit into, if the survey respondent felt prepared to address it, strategies used, and whether or not their approach worked, along with other demographic questions.

The authors of the abstract, “Tracking Pediatric Health Misinformation Clinicians Hear to Build an Institutional Response," found that more than 50% of the misinformation recorded at Children’s Hospital of Philadelphia (CHOP) involved vaccines, as well as topics including aluminum, acetaminophen, ADHD, and supplements. The survey results provided a snapshot of what patients and families were most concerned about when it comes to their children’s health.

CHOP researchers used the data to create Pediatric Health Chat, an externally facing website that contained educational information that debunked the misinformation families reported from their everyday lives. They also used the results to develop internal educational trainings for hospital practitioners.

“Looking at these trends allowed us to see in real-time what was worrying the families we care for and allowed us to give them the most up to date science on topics of interest,” said Katie Lockwood, MD, MEd, FAAP, study author and pediatrician at CHOP.  "Addressing pediatric health misinformation is vital to protecting the health of children, and as trusted messengers, children's hospitals have an obligation to respond."

The research showed that systematically tracking the misinformation families encounter can turn clinicians’ real-world questions into effective, targeted education. Although fewer than one-third of survey respondents said their own responses worked, the findings gave providers a clearer understanding of families’ concerns and helped guide materials for patients, families and other clinicians.

Researchers state this approach could be replicated in other hospitals and care settings to help build trust with patients and caregivers and provide them the information they need most to keep children healthy.

Media Relations Contact:

Natalie Solimeo at solimeon@chop.edu.

 

Study author Dr. Katie Lockwood, is scheduled to present her research, which is below, from 5 to 6 PM on Saturday, Oct. 3 at the Marriott.

In addition, Dr. Lockwood will be among highlighted abstract authors who will give brief presentations and be available for interviews during a “Soundbite Session” from noon- 1 pm PDT Sunday, Oct. 4, in the conference center Press Office, 14A.

##

The American Academy of Pediatrics is an organization of 67,000 primary care pediatricians, pediatric medical subspecialists and pediatric surgical specialists dedicated to the health, safety and well-being of infants, children, adolescents and young adults. For more information, visit www.aap.org. Reporters can access the meeting program and other relevant meeting information through the AAP meeting website at http://www.aapexperience.org/

 

ABSTRACT

Program Name: Call for Abstracts

Submission Type: Council on Clinical Information Technology

Abstract Title: Tracking Pediatric Health Misinformation Clinicians Hear to Build an Institutional Response

Katie Lockwood

Ambler, PA, United States


Health misinformation is a threat to public health and increasingly is impacting pediatric clinical care. In order to better understand how misinformation impacts patients at our hospital, we developed a REDCap tracking tool for clinicians to report misinformation heard during clinical encounters. We use the trending topics in that tracker to develop new educational content for an external website called Pediatric Health Chat and for internal educational trainings at Children's Hospital of Philadelphia.

A REDCap survey tracking tool for misinformation was created and distributed across Children's Hospital of Philadelphia clinical environments, on fliers, emails, and linked in our EHR, EPIC. This survey ask what misinformation was heard, the category it fits it, if the respondent felt prepared to address it, strategies used, and whether or not their approach worked, along with other respondent demographic questions. A Qliksense dashboard was created for real time insights on survey entries. A multidisciplinary team (including a pediatrician, neonatologist, public relations and marketing specialists, data analyst, and journalist) meets monthly to review trends and determine which topics necessitate novel patient education content creation and internal clinician education.

From May 2025 to March 2026, there have been 234 entries. Vaccine misinformation accounts for 53.8% of entries. Trending keywords include aluminum, acetaminophen, ADHD, and antibiotics. On a scale of 1 to 100, respondents reported a median preparedness score of 77 in responding to misinformation from patients and yet only 28% reported that their approach worked. Median preparedness scores increased with years of practice (Figure 1), yet more years in practice was associated with lower chances of their approach working (Figure 2). These entries have resulted in the creation of new patient education and public health social media content on 28 topics, including videos and blog posts, and 7 corresponding Opinion Editorials in the Philadelphia Inquirer. In addition, a weekly educational email on vaccine communication skills was started with 10 weeks and counting of clinician education content informed by the REDCap entries.

Using a survey tool to collect local trends in misinformation in clinical encounters can drive patient-facing education, institutional public health messaging, and clinician education initiatives. While vaccine misinformation remains a majority of medical myths heard by clinicians, the topics range across categories such as distrust in healthcare, supplements, miracle cures, and unnecessary interventions. A systematic approach to monitoring local misinformation trends can provide a targeted response to the misinformation topics that are most likely to impact clinical care in a particular patient community. The system in place at Children's Hospital of Philadelphia could be a model for other institutions to respond similarly.

Figure 1. Median Preparedness Score by Years of Experience

 

Figure 2. Percent of Approach Working to Change Patient/Family Perspectives

 

 

 

TikTok misinformation content on acetaminophen and autism surged after presidential announcement



A majority of misinformation was created by influencers rather than medical professionals




American Academy of Pediatrics






SAN DIEGO —— Misinformation linking acetaminophen use during pregnancy to autism in children rose on TikTok after an announcement from the Food and Drug Administration, according to research presented during the American Academy of Pediatrics 2026 National Conference & Exhibition Oct. 2-6, 2026, at the San Diego Convention Center.

The FDA announced a label change for acetaminophen products such as Tylenol on September 22, 2025, prompting a wave of confusion and concern that brought users to the internet in search of accurate information. On TikTok, however, they were more likely to encounter misinformation from influencers without medical expertise.

The abstract, titled, “Acetaminophen Use During Pregnancy and Autism on TikTok: Disproportionate Exposure to Misinformation in a Content Analysis,” analyzed 53 TikTok videos posted immediately after the announcement between September 2025 and November 2025, and found that about 53% contained evidence-consistent information, while about 28% contained outright misinformation.

“Despite being a smaller portion of the overall available subject content, the misinformation videos accounted for over half of the total views of all the content we examined,” Shivani Srivastava, Medical Student at Rutgers School of Medicine said.

“Our results indicate that TikTok’s algorithm amplified low-quality, conspiracy-framed videos containing misinformation on a very sensitive health topic and allowed for misinformation videos to spread far wider than evidence-based videos that explained the lack of causal evidence between prenatal acetaminophen exposure and autism.”

A single misinformation video reached 10.3 million views, representing a third (36.6%) of all exposure across content analyzed. Additionally, nearly 3/4 of the videos containing misinformation were created by influencers as opposed to medical professionals.

Researchers state that as more people turn to social media, and especially TikTok, for medical advice, it becomes increasingly important for pediatricians to proactively address misinformation with patients and their families.

“After seeing pregnant patients in our own clinics question whether it was safe to take Tylenol during pregnancy, we wanted to understand what information they were being exposed to online,” Srivastava said. “Our findings reveal how important it is for medical institutions to be part of the conversations on social media by sharing accurate, engaging content that reaches patients where they are.”

 

Media Relations Contact: Lavene Gass, lag311@njms.rutgers.edu

 

Study author Katherine Poole is scheduled to present the research, which is below, from 10:20 to 10:30 a.m. PDT on Sunday, Oct. 4 at the Marriott.

 

In addition, Ms. Poole will be among highlighted abstract authors who will give brief presentations and be available for interviews during a “Soundbite Session” from noon- 1 pm PDT Sunday, Oct. 4, in the conference center Press Room, 14A.

 

##

The American Academy of Pediatrics is an organization of 67,000 primary care pediatricians, pediatric medical subspecialists and pediatric surgical specialists dedicated to the health, safety and well-being of infants, children, adolescents and young adults. For more information, visit www.aap.org. Reporters can access the meeting program and other relevant meeting information through the AAP meeting website at http://www.aapexperience.org/

 

Program Name: Call for Abstracts

Submission Type: Council on Adolescents and Young Adults

Abstract Title: Acetaminophen Use During Pregnancy and Autism on TikTok: Disproportionate Exposure to Misinformation in a Content Analysis

Katherine Poole

Hoboken, NJ, United States


 

TikTok is a primary source of health information for adolescents and young adults, a population at particular risk when algorithmic amplification accelerates the spread of medical misinformation. In September 2025, public attention to a proposed association between prenatal acetaminophen exposure and autism spectrum disorder (ASD), despite the absence of causal evidence, triggered a rapid surge of TikTok content on the topic. Misinformation in this environment poses direct risk to prenatal health decision-making among young people of reproductive age.

 

We conducted a cross-sectional content analysis of 53 TikTok videos posted between September and November 2025, identified using the search terms "tylenol autism," "acetaminophen autism," "paracetamol autism," and #tylenol (IRB approval: Pro2026000574). Two reviewers independently coded videos for misinformation status, creator type, educational quality using the validated Global Quality Scale (GQS), thematic framing, and engagement metrics. Inter-rater reliability for misinformation classification was substantial (Cohen's kappa = 0.86). Group differences were assessed using Fisher's exact test and Kruskal-Wallis tests. Independent predictors of misinformation were assessed using Firth penalized logistic regression. All analyses were performed in R version 4.5.3.

 

Of 53 videos, 52.8% were evidence-consistent, 28.3% contained misinformation, and 18.9% were mixed or uncertain. Health professionals produced exclusively evidence-consistent content, while influencers accounted for 73.3% of all misinformation videos (p < 0.001). Misinformation videos were of significantly lower educational quality than evidence-consistent videos (mean GQS 1.73 vs. 4.18, p < 0.001) and were more likely to include conspiracy framing (46.7%) and pharmaceutical distrust (53.3%, p < 0.001). Despite comprising only 28.3% of videos, misinformation accounted for 52.4% of total views across 28.13 million total views. A single misinformation video reached 10.3 million views, representing 36.6% of all exposure across analyzed videos. In logistic regression, lower educational quality and conspiracy framing were each independently associated with misinformation (p < 0.001 and p = 0.012, respectively), while creator type was not independently significant after adjustment.

 

TikTok's recommendation algorithm disproportionately amplified low-quality, conspiracy-framed content during this health controversy, giving misinformation far greater reach than evidence-based videos. Pediatricians should proactively address this content in clinical conversations with patients of reproductive age. Broader solutions will require platform-level content moderation and coordinated public health responses to counter misinformation on platforms widely used by adolescents and young adults.

 

Figure 1. Educational quality and exposure of TikTok videos discussing acetaminophen use during pregnancy and autism spectrum disorder risk (N = 53).

 

Each bubble represents one video. The x-axis shows Global Quality Scale (GQS) score and the y-axis shows total view count (log scale). Bubble size reflects share count, while shape indicates creator type and color indicates content classification. The y-axis is log-scaled to account for the wide range of view counts.

Figure 2. Predictors of misinformation in TikTok videos discussing acetaminophen use during pregnancy and autism spectrum disorder risk (N = 53), estimated using Firth penalized logistic regression.

 

Diamonds represent odds ratios and horizontal lines represent 95% confidence intervals. Red indicates statistical significance (p < 0.05) and blue indicates non-significance (p ≥ 0.05). The dashed vertical line marks the null (OR = 1).

 

 

Social media analysis finds health institutions delayed or did not respond to false claims inking autism to acetaminophen use during pregnancy



Audit of Instagram posts shows American Academy of Pediatrics was the exception in responding to misinformation




American Academy of Pediatrics






SAN DIEGO — Most public health institutions failed to respond in a timely way to misinformation on social media that falsely claimed that acetaminophen during pregnancy is linked to autism, according to research presented during the American Academy of Pediatrics 2026 National Conference & Exhibition.

Researchers reviewed public social media (Instagram) posts from 65 accounts including top children’s hospitals, medical societies, and state health departments, auditing accounts to assess their response to popular misinformation on this topic from September through November, 2025. They identified the American Academy of Pediatrics (AAP) as the fastest and most active account to respond during this time, according to authors.

“As social media grows in popularity as a source of medical information, it is imperative to understand the ways trusted sources communicate this information,” said author Jessica Visone, a medical student at Rutgers New Jersey Medical School. She will present the abstract, “Administrative Gaps in Digital Patient Engagement: An Audit of Institutional Responsiveness to the 2025 Acetaminophen-Autism Controversy,” during the Oct. 2-6 conference in San Diego.

“We need to ensure the right information is reaching the appropriate audiences to promote health and well-being for all. At a time of increased misinformation, there is nothing more powerful than the truth when it comes to population health.”

The research audits the timeliness and quality of digital communications from pediatric organizations following messaging from the White House on September 22, 2025, linking acetaminophen use to autism. 

The analysis found only 14 of 65 institutions (21.5%) of the accounts posted anything relevant to correct false claims concerning the purported cause of autism. None of the state health departments addressed the topic and children’s hospitals took as long as 51 days to address the topic, according to research. The AAP responded on Day 1 and posted 10 relevant posts over the time period.

Of the 26 relevant posts analyzed, all used plain-language formatting and myth-busting framing, but the average reading level was well above the average 8th-grade reading level in the U.S., according to the research. No multilingual content was identified across any institution.

“Overall, through this audit of major pediatric health institutions, we found a limited and delayed response to an active health controversy,” Visone said. “Major health organizations have a responsibility to communicate with the populations they serve during times of increased health misinformation.”

The full team who contributed to this research included Kathryn Whitehill, MD, and medical students: Shivani Srivastava and Katherine Poole. 

Media Relations Contact:

Lavene Gass, lag311@njms.rutgers.edu

Contact: Jessica Visone

Email: jnv38@njms.rutgers.edu

 

Ms. Visone is scheduled to present a poster, described in the abstract below, between 11 am – 1 pm PT Saturday, Oct. 3 for the Section on Administration and Practice Management, H3062.

In addition, Ms. Visone, second-year medical student, will be among highlighted abstract authors who will give brief presentations and be available for interviews during a “Soundbite Session” from noon- 1 pm PT Sunday, Oct. 4, in the conference center Press Room, 14A.

 

##

The American Academy of Pediatrics is an organization of 67,000 primary care pediatricians, pediatric medical subspecialists and pediatric surgical specialists dedicated to the health, safety and well-being of infants, children, adolescents and young adults. For more information, visit www.aap.org. Reporters can access the meeting program and other relevant meeting information through the AAP meeting website at http://www.aapexperience.org/

 

ABSTRACT

Submission Type: Section on Administration and Practice Management 

Abstract Title: Administrative Gaps in Digital Patient Engagement: An Audit of Institutional Responsiveness to the 2025 Acetaminophen-Autism Controversy 

Jessica Visone 


In September 2025, claims linking prenatal acetaminophen use to autism spectrum disorder spread rapidly across social media, despite the lack of causal evidence. Pediatric families rely on trusted institutions, such as hospitals, state departments, and national organizations for accurate health information, yet little is known about how quickly and effectively these institutions respond during active health information controversies. This study audits the timeliness and quality of digital communications from pediatric organizations following messaging from the White House on September 22, 2025 linking acetaminophen use to autism, using guidance from the American Academy of Pediatrics (AAP) as a benchmark. 

We conducted a cross-sectional audit of public Instagram accounts between September 22 and November 15, 2025, from 65 health organizations, including the top children's hospitals for pediatric and adolescent behavioral health, professional medical societies, and state health departments serving the largest pediatric populations. We measured time to first relevant post, proportion of controversy-related content, and communication quality. Quality was assessed using Flesch-Kincaid grade level, SMOG index, multilingual availability, and accessibility features. All analyses were conducted in R version 4.5.3. 

Only 14 of 65 institutions (21.5%) posted content addressing the controversy. The AAP responded on Day 1 and published 10 relevant posts across the study period. No state health departments posted any relevant content. Among institutions that did post, hospital responses lagged up to 51 days behind the AAP. Non-responding institutions were not inactive: some published over 100 posts on unrelated topics during the same period, suggesting silence reflected administrative choice rather than limited capacity. Of the 26 relevant posts analyzed, 85% used plain-language formatting and myth-busting framing, but the average reading level was Flesch-Kincaid grade 11.4, well above the average 8th-grade reading level in the US. No multilingual content was identified across any institution. 

The AAP demonstrated that rapid, high-quality digital communication is achievable during a fast-moving health controversy. Most pediatric hospitals and all state health departments in this sample failed to match that standard, leaving families without institutional guidance during an active misinformation event. These findings point to a gap in administrative infrastructure and policy, not just content. Pediatric health systems should develop standardized rapid-response protocols that include pre-approved messaging templates written at or below an 8th-grade reading level, multilingual content, and clear internal processes for activating effective and accessible communication during emerging controversies. This study offers a practical framework for evaluating and strengthening that capacity to improve accessibility of health information for pediatric families, especially during periods of widespread misinformation. 

Figure 1. Timeline of Institutional Responses to the Acetaminophen–Autism Controversy. 

 

Horizontal bars represent the number of days from September 22, 2025, to each institution’s first relevant Instagram post, indicated by the point. Point size indicates the total number of relevant posts published by each institution during the study period. State health departments are not depicted due to lack of posts during study period. 

Figure 2. Prevalence of Content Quality and Accessibility Features in Relevant Instagram Posts (n = 26).  

 

Percentages indicate the proportion of posts incorporating specific digital communication features, grouped by format, content framing, emotional tone, and accessibility. 

 

 

 

Study shows growing injuries from electronic bicycles, electronic scooters with differences in injuries, hospitalizations



E-bike injuries were considerably more severe although less common than injuries from e-scooters




American Academy of Pediatrics






SAN DIEGO — Electronic bikes and electronic scooter injuries among children and teens increased nearly four-fold at one California hospital between 2019 and 2025, according to research presented during the American Academy of Pediatrics 2026 National Conference & Exhibition in San Diego. 

 Although e-scooters accounted for most injuries, e-bike injuries represented a growing share of cases and were considerably more severe. Children injured on e-bikes were more likely to sustain concussions and fractures, require surgery or hospitalization, and were more likely to experience potentially life-threatening injuries, according to the research to be presented during the Oct. 2-6 conference. 

The authors of the abstract, “Patterns and Severity of Injuries Following E-Bike and E-scooter Use,” also found that many riders – especially those riding e-scooters -- were violating age or helmet laws. Yet legal compliance alone was not associated with less severe injuries. 
 
"Our data highlights that an intentional and nuanced approach to education, community awareness, and public safety measures around e-bike and e-scooter use is imperative, especially regarding our youth population," said Bianca Edison, MD, MS, FAAP, FAMSSM, an attending physician in the Jackie and Gene Autry Orthopedic Center at Children’s Hospital Los Angeles. 

Researchers reviewing data at a pediatric hospital analyzed 379 cases, 70% of whom were male. In 2025, there were 124 cases reported, up from 33 in 2019.  E-bike injuries represented a growing proportion of total cases, rising from 21% in 2019 to 31% in 2025. E-scooter injuries comprised 77% of cases.  

Most injuries resulted from an unprovoked fall or loss of control (71%). Upper extremity (53%), lower extremity (46%), and head (39%) were the most frequent injury locations. Despite an overall greater proportion of e-scooter injuries, e-bike riders experienced significantly worse outcomes than e-scooter riders across all injury severity measures, 17% experiencing a concussion; 48% a fracture; 26% needed surgery; and 27% required impatient admission.  

“These recreational transportation devices are becoming increasingly common among children and teenagers, and the injuries we are seeing are rising just as quickly,” said Dr. Edison. “It is imperative that youth, parents, and the community at large realize that preventing these injuries will require safety strategies that account for the different risks associated with each type of device and the implications of their use in public amongst other riders, pedestrians, and motor vehicle drivers, rather than a one-size-fits-all approach.” 
   
Media Relations Contacts: 

Lauren Song: lasong@chla.usc.edu / 323-361-3614 

Jack Wyatt, clinical research coordinator at the Jackie and Gene Autry Orthopedic Center, Children’s Hospital Los Angeles, is scheduled to present the research, which is below, from 8:49 am PDT – 8:53 am PDT Saturday, Oct. 3, 2026 

In addition, Jack Wyatt will be among highlighted abstract authors who will give brief presentations and be available for interviews during a “Soundbite Session” from noon- 1 pm PDT Sunday, Oct. 4, in the conference center Press Room, 14A. 

##

The American Academy of Pediatrics is an organization of 67,000 primary care pediatricians, pediatric medical subspecialists and pediatric surgical specialists dedicated to the health, safety and well-being of infants, children, adolescents and young adults. For more information, visit www.aap.org. Reporters can access the meeting program and other relevant meeting information through the AAP meeting website at http://www.aapexperience.org/

 

ABSTRACT

Program Name: Call for Abstracts 

Submission Type: Section on Orthopaedics 

Abstract Title: Patterns and Severity of Injuries Following E-Bike and E-scooter Use 

John Wyatt 

Los Angeles, CA, United States 

10/03/2026 8:49 AM - 8:53 AM 

The use of electric bikes (e-bikes) and scooters (e-scooters) has expanded in urban environments, particularly among adolescents. Injury rates appear to be rising, yet detailed characterization in pediatric populations remains limited. This study evaluates trends in injury incidence, mechanisms, and outcomes associated with e-bike and e-scooter use, with emphasis on injury severity and legal compliance. 

A large language model was utilized to identify patients with injuries related to the use of e-bikes or e-scooters at a single quaternary pediatric hospital from 2019 to 2025. Demographic, clinical, and injury characteristics were collected from medical records. Illegal riding was defined as operating an e-scooter under the age of 16 or riding an e-bike under the age of 18 without a helmet, consistent with California laws. Injury severity was assessed using the Pediatric Trauma Score (PTS). Comparisons between e-bike and e-scooter injury types and injury severity were compared using chi-square, Fisher’s exact, and Wilcoxon rank-sum tests as appropriate. 

379 patients were included (70% male, mean age 14.2±3.8 years). E-bike and e-scooter injuries increased nearly four-fold over the study period, from 33 cases in 2019 to 124 cases in 2025. E-bike injuries represented a growing proportion of total cases, rising from 21% in 2019 to 31% in 2025. E-scooter injuries comprised 77% of cases. The most common mechanism of injury was unprovoked fall or loss of control (71%). Upper extremity (53%), lower extremity (46%), and head (39%) were the most frequent injury locations. Despite an overall greater proportion of e-scooter injuries, e-bike riders experienced significantly worse outcomes than e-scooter riders across all injury severity measures: concussion (17% vs 8.6%, p=0.030), fracture (48% vs 36%, p=0.049), need for surgery (26% vs 9..7%, p< 0.001), and impatient admission (27% vs 10%, p< 0.001). A greater proportion of e-bike injuries were also classified as potentially life-threatening by PTS (8.8% vs 2.8%, p=0.027). Illegal riding was identified in 53% of patients and was significantly more prevalent among e-scooter riders (66% vs 7.2%, p< 0.001). However, after adjusting for age, vehicle type, and helmet use, law compliance was not associated with less severe injury outcomes (p=0.849). 

E-bike and e-scooter-related injuries in pediatric patients are increasing rapidly, with e-bike injuries representing a growing and disproportionately severe subset despite lower overall prevalence. These findings highlight important differences in injury profiles between device types and suggest that factors beyond simple legal compliance may drive injury severity. The high prevalence of illegal riding underscores ongoing gaps in adherence to safety regulations, particularly among e-scooter users. Collectively, this study supports the need for targeted injury prevention strategies, including improved education, enforcement, and device-specific safety interventions, to address the rising burden of electric micromobility-related injuries in pediatric populations. 

Pediatric E-Bike and E-scooter Injuries by Year 

 

Numbers within bars represent injury count by vehicle type. Total injuries per year show above each bar.

 

 

 

King’s College London joins London-wide partnership awarded £22 million to transform health and social care through research



King’s College London is co-leading a new partnership uniting London’s health and care community, underpinned by a significant investment in the city’s research infrastructure





King's College London


Backed by £22 million of government funding, the NIHR London Applied Research Collaboration (ARC) brings together NHS trusts, universities, and other expertise from across the capital to tackle some of the UK’s most pressing health and social care research priorities. 

ARC London will be hosted by Guy’s and St Thomas’ NHS Foundation Trust, with the leadership team based at King’s College London, University College London and Imperial College London, and partners spanning 20 organisations, including across King’s Health Partners. 

The partnership will provide high-quality health and social care research and support the translation of evidence into practice, playing a critical role in making sure research delivers real-world improvements in health and care for patients, communities and the public. 

The new ARC London joins a collaborative network of 11 ARCs spread across the country. The ARCs work together to share expertise and learning to support research and implementation at scale. 

Addressing the biggest challenges in health and social care 

ARC London will focus on four research themes that address the biggest challenges in the health and social care sectors: 

  • Neighbourhood health and social care: supporting independent living, reducing emergency hospital visits, and better helping people with multiple health and care needs throughout their lives  

  • Prevention and early intervention in people with major conditions, such as cardiovascular, renal and metabolic disease and mental ill health 

  • Productivity and economic growth, to support the highest quality health and care services at an affordable cost 

  • Data sciences for healthcare, to help understand people’s health and care needs earlier to prevent illness and improve care  

King’s College London brings expertise in population health, data science and social science, alongside strong experience in major health challenges including mental health, maternal and child health, cardiometabolic disease and respiratory disease.  

Ingrid Wolfe, Professor of Paediatrics & Child Population Health at King’s College London and Guy’s and St Thomas’ is Co-Director of ARC London, joining the leadership team alongside ARC London Director Professor Laura Shallcross from University College London and Deputy Director Dr Ana Luisa Neves from Imperial College London.  

Professor Wolfe said: “We have a golden opportunity to deliver research that will genuinely improve outcomes for our patients and the public, and I’m excited to start working with so many talented partners. 

“At a time when the NHS is focused on prevention, neighbourhood care and innovation, ARC London provides a unique opportunity to generate the evidence needed to support lasting transformation across health and social care.” 

ARC London will respond to the issues that matter most to people living with the greatest burden of disease in London and beyond. It will help to address health inequalities by embedding inclusive approaches across all projects and programmes to ensure that findings can be used more widely and are relevant for a broad and diverse population, and any resulting intervention can be successfully delivered to the people who need it most.  

King’s researchers are leading collaboration across themes to benefit people living with multiple long-term conditions and children and young people, and King’s Policy Institute is supporting the ARC’s efforts to connect research to improvements in policy and practice. 

Mieke Van Hemelrijck, Professor in Cancer Epidemiology at King’s College London, is leading work focused on adults with multiple long-term conditions. She said: “This collaboration brings together researchers from across London with expertise spanning a wide range of diseases, populations and research approaches, and I’m particularly excited about the possibilities that brings. 

“Multiple long-term conditions are inherently complex, so no single discipline or disease area can address them alone. Combining our expertise will allow us to ask more ambitious questions and translate research into greater impact for patients and the NHS.” 

ARC London will also partner with other NIHR ARCs, NIHR infrastructure across London and partners in the life sciences sector, creating collaborations to support innovative new medicines, technology and models of care into practice sooner. 

The funding for ARC London is part of NIHR’s £170 million investment to support 11 ARCs over five years. 

Professor Marian Knight, Scientific Director for NIHR Infrastructure, said: "This new London ARC will play a vital role in turning research into real-world improvements in health and care, generating evidence across the capital that benefits communities nationwide. By bringing together partners from every corner of London, we have a unique opportunity to collaborate, innovate, drive economic growth, and deliver meaningful impact for patients.”